Ocular Therapeutix (OCUL) Shares Issued (2013 - 2026)
Ocular Therapeutix's quarterly Shares Issued came in at $294000.0 in Q1 2026, down 92.97% year-on-year from $4.2 million in Q1 2025, and down 99.94% quarter-over-quarter from $522.0 million in Q4 2025.
Ocular Therapeutix has reported Shares Issued for 14 years, with the latest figure at $294000.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued fell 92.97% year-over-year to $294000.0; the trailing twelve-month figure through Mar 2026 stood at $710.3 million (up 328.29% YoY), and the FY2025 full-year result was $539.6 million, up 53008.76% from the prior year.
- Shares Issued for Q1 2026 stood at $294000.0, down from $522.0 million in the prior quarter.
- The five-year high for Shares Issued was $522.0 million in Q4 2025, with the low at -$309.8 million in Q2 2024.
- Average Shares Issued over 5 years is $45.4 million, with a median of $438500.0 recorded in 2022.
- Peak annual rise in Shares Issued reached 405480.77% in 2024, while the deepest fall reached 3610.64% in 2024.
- Tracing OCUL's Shares Issued over 5 years: stood at $32000.0 in 2022, then slumped by 75.0% to $8000.0 in 2023, then jumped by 6450.0% to $524000.0 in 2024, then surged by 99514.12% to $522.0 million in 2025, then sank by 99.94% to $294000.0 in 2026.
- The last three Shares Issued figures came in at $294000.0 (Q1 2026), $522.0 million (Q4 2025), and $94.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | 294,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 294,000.00 |
| Mar 31, 2026 | 294,000.00 |
| Dec 31, 2025 | 521.98 Mn |
| Dec 31, 2025 | 521.98 Mn |
| Sep 30, 2025 | 94.03 Mn |
| Sep 30, 2025 | 94.03 Mn |
| Jun 30, 2025 | 94.03 Mn |
| Jun 30, 2025 | 94.03 Mn |
| Mar 31, 2025 | 4.18 Mn |
| Mar 31, 2025 | 4.18 Mn |
| Dec 31, 2024 | 524,000.00 |
| Dec 31, 2024 | 524,000.00 |
| Sep 30, 2024 | -6.08 Mn |
| Sep 30, 2024 | -6.08 Mn |
| Jun 30, 2024 | -309.78 Mn |
| Jun 30, 2024 | -309.78 Mn |
| Mar 31, 2024 | 316.35 Mn |
| Mar 31, 2024 | 316.35 Mn |
| Dec 31, 2023 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | 708,000.00 |
| Sep 30, 2023 | 708,000.00 |
| Jun 30, 2023 | 8.82 Mn |
| Jun 30, 2023 | 8.82 Mn |
| Mar 31, 2023 | 78,000.00 |
| Mar 31, 2023 | 78,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Jun 30, 2022 | 353,000.00 |
| Jun 30, 2022 | 353,000.00 |
| Mar 31, 2022 | 129,000.00 |
| Mar 31, 2022 | 129,000.00 |
| Dec 31, 2021 | 2.10 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | -1.25 Mn |
| Sep 30, 2021 | -1.25 Mn |
| Jun 30, 2021 | 538,000.00 |
| Jun 30, 2021 | 538,000.00 |
| Mar 31, 2021 | 1.20 Mn |
| Mar 31, 2021 | 1.20 Mn |
| Dec 31, 2020 | 223.64 Mn |
| Dec 31, 2020 | 223.64 Mn |
| Jun 30, 2020 | 1.67 Mn |
| Jun 30, 2020 | 1.67 Mn |
| Mar 31, 2020 | 128,000.00 |
| Mar 31, 2020 | 128,000.00 |
| Dec 31, 2019 | 8.89 Mn |
| Dec 31, 2019 | 8.89 Mn |
| Sep 30, 2019 | 18.62 Mn |
| Sep 30, 2019 | 18.62 Mn |
| Jun 30, 2019 | 5.07 Mn |
| Jun 30, 2019 | 5.07 Mn |
| Mar 31, 2019 | 4.95 Mn |
| Mar 31, 2019 | 4.95 Mn |
| Dec 31, 2018 | 26.48 Mn |
| Dec 31, 2018 | 26.48 Mn |
| Sep 30, 2018 | 12.85 Mn |
| Sep 30, 2018 | 12.85 Mn |
| Jun 30, 2018 | 8.39 Mn |
| Jun 30, 2018 | 8.39 Mn |
| Mar 31, 2018 | 34.99 Mn |
| Mar 31, 2018 | 34.99 Mn |
| Dec 31, 2017 | 29.08 Mn |
| Dec 31, 2017 | 29.08 Mn |
| Sep 30, 2017 | 1.57 Mn |
| Sep 30, 2017 | 1.57 Mn |
| Jun 30, 2017 | 855,000.00 |
| Jun 30, 2017 | 855,000.00 |
| Mar 31, 2017 | 1.56 Mn |
| Mar 31, 2017 | 1.56 Mn |
| Dec 31, 2016 | 626,000.00 |
| Dec 31, 2016 | 626,000.00 |
| Sep 30, 2016 | 78,000.00 |
| Sep 30, 2016 | 78,000.00 |
| Jun 30, 2016 | 70,000.00 |
| Jun 30, 2016 | 70,000.00 |
| Mar 31, 2016 | 5,000.00 |
| Mar 31, 2016 | 5,000.00 |
| Dec 31, 2015 | 32,000.00 |
| Dec 31, 2015 | 32,000.00 |
| Sep 30, 2015 | -65.47 Mn |
| Sep 30, 2015 | -65.47 Mn |
| Jun 30, 2015 | 65.61 Mn |
| Jun 30, 2015 | 65.61 Mn |
| Mar 31, 2015 | 34,000.00 |
| Mar 31, 2015 | 34,000.00 |
| Dec 31, 2014 | -69.48 Mn |
| Dec 31, 2014 | -69.48 Mn |
| Jun 30, 2014 | 3,000.00 |
| Jun 30, 2014 | 3,000.00 |
| Mar 31, 2014 | 21,000.00 |
| Mar 31, 2014 | 21,000.00 |
| Dec 31, 2013 | 5,000.00 |
| Dec 31, 2013 | 5,000.00 |